Evidence map›Paper›PMID 25425455›Full record

ArticleParasites & vectors2014

Field-derived Schistosoma mansoni and Biomphalaria pfeifferi in Kenya: a compatible association characterized by lack of strong local adaptation, and presence of some snails able to persistently produce cercariae for over a year.

Martin W Mutuku, Celestine K Dweni, Moses Mwangi, Joseph M Kinuthia, Ibrahim N Mwangi, Geoffrey M Maina, Lelo E Agola, Si-Ming Zhang, Rosebella Maranga, Eric S Loker and 1 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Genetic Diversity and Infection Prevalence ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Host preference of field-derivedEcosphere (Washington, D.C) · 2022
    Article
  13. Observational
  14. Article
  15. Article
  16. Invasion and Dispersal ofFrontiers in medicine · 2021
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Martin W MutukuCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. mmutuku@kemri.org.
Celestine K DweniCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. slestynn@gmail.com.
Moses MwangiCentre for Public Health Research, KEMRI, P.O Box 20752-00200, Nairobi, Kenya. rewelmwangi@yahoo.com.
Joseph M KinuthiaCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. jkinuthia@kemri.org.
Ibrahim N MwangiCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. indungu@kemri.org.
Geoffrey M MainaCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. gmaina@kemri.org.
Lelo E AgolaCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. elelo@kemri.org.
Si-Ming ZhangCenter for Evolutionary and Theoretical Immunology, Department of Biology, and Parasitology Division, Museum of Southwestern Biology, University of New Mexico, Albuquerque, 87131, U.S.A. zhangsm@unm.edu.
Rosebella MarangaDepartment of Zoology, Jomo Kenyatta University of Agriculture and Technology, P.O Box 62000-00200, Nairobi, Kenya. bellamaranga2010@yahoo.com.
Eric S LokerCenter for Evolutionary and Theoretical Immunology, Department of Biology, and Parasitology Division, Museum of Southwestern Biology, University of New Mexico, Albuquerque, 87131, U.S.A. esloker@unm.edu.
Gerald M MkojiCentre for Biotechnology Research and Development, Kenya Medical Research Institute (KEMRI), P.O Box 54840-00200, Nairobi, Kenya. gmkoji@kemri.org.
Kenya Medical Research Institute · KEUniversity of New Mexico · USJomo Kenyatta University of Agriculture and Technology · KE

Funding

UNM COBRE: THEORETICAL STUDY OF SPECIFICITY OF RNA SILENCING MECHANISMP20RR018754 · NCRR · UNIVERSITY OF NEW MEXICO · PI LOKER, ERIC SAMUEL · 2003 to 2011
$16.7M
Snail-Related Studies of Transmission & Control of Schistosomiasis in KenyaR37AI101438 · NIAID · UNIVERSITY OF NEW MEXICO · PI ERIC SAMUEL LOKER · 2017 to 2026
$3.7M
Snail-Related Studies of Transmission and Control of Schistosomiasis in KenyaR01AI101438 · NIAID · UNIVERSITY OF NEW MEXICO · PI LOKER, ERIC SAMUEL · 2012 to 2016
$1.7M
NCRR NIH HHS P20 RR018754NCRR NIH HHS P20RR18754NIAID NIH HHS AI101438NIAID NIH HHS R01 AI101438NIAID NIH HHS R37 AI101438
6 · The paper itself

Abstract

backgroundSchistosoma mansoni is widely distributed in sub-Saharan Africa with Biomphalaria pfeifferi being its most widespread and important snail intermediate host. Few studies have examined the compatibility of field-derived B. pfeifferi snails with S. mansoni miracidia derived from human hosts. We investigated compatibility (as defined by shedding of cercariae following exposure to miracidia) of two isolates of S. mansoni from school children from Asao (western Kenya) and Mwea (central Kenya) with B. pfeifferi collected directly from Asao stream or the Mwea rice fields.

methodsWe exposed snails from both regions to four different doses of miracidia (1, 5, 10 and 25) from sympatric or allopatric S. mansoni, and maintained them in a shaded, screened out-of-doors rearing facility in Kisian, in western Kenya. Both snail survival and the number of snails that became infected were monitored weekly. This was done for 25 weeks post-exposure (PE). Those infected snails which survived beyond this period were monitored until they all died.

resultsAlthough overall survival of Mwea snails maintained in western Kenya was generally low, both sympatric and allopatric combinations of parasites and snails exhibited high compatibility (approximately 50% at a dose of one miracidium per snail), with an increase in infection rates as the miracidial dose was increased (P < 0.002). Schistosomes were no more compatible with sympatric than allopatric snails, nor were snails less compatible with sympatric than allopatric schistosomes. Snail mortality increased significantly with dose of miracidia (P < 0.05). Approximately 3% of Asao snails exposed to a low dose of sympatric miracidia (1 or 5) continued to shed cercariae for as long as 58 weeks post exposure.

conclusionsThere were no significant local adaptation effects for either schistosomes or snails. Also, the existence of "super-survivor" snails is noteworthy for its implications for current control initiatives that mostly rely on mass drug administration (MDA). Long-term shedders could provide an ongoing source of cercariae to initiate human infections for many months, suggesting care is required in considering how human MDA treatments are timed. Future control programs should incorporate means to eliminate infected snails to complement chemotherapy interventions in controlling schistosomiasis.

Indexed as

Adaptation, PhysiologicalAnimalsBiomphalariaCercariaChildFecesHumansKenyaOdds RatioSchistosoma mansoniSchistosomiasis mansoni

Identifiers

PMID25425455
PMCPMC4253995
OpenAlexW2164107898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.